NASH, Fatty Liver, Cirrhosis
Non Alcoholic Steatohepatitis (NASH) is a type of fatty liver disease, characterized by inflammation of the liver with concurrent fat accumulation in liver .
NASH is closely related to the triple epidemic of obesity, pre-diabetes, and diabetes. If you are living with NASH you may qualify for a clinical research study.
Join Encore Borland Groover Clinical Research (EBGCR) for a complimentary Fibroscan test for fatty liver.
ClinicalTrials.gov Study Details
Liver-biopsy Proven NASH
A phase 2b randomized, double blind, placebo-controlled, multicenter study evaluating safety and efficacy of EDP-305 in subjects with liver-biopsy proven non-alcoholic steatohepatitis (NASH) (ARGON-2)
Clinical Research Location 4800 Belfort Road Jacksonville FL 32256
Contact Research: (904) 680-0871
Research Email: ACorregidor@EncoreDocs.com
Clinical Research Location 1679 Eagle Harbor Parkway Suite D Fleming Island FL 32003
Contact Research: (904) 621-0390
Research Email: MHerman@EncoreDocs.com
Clinical Research Location 4800 Belfort Road Jacksonville FL 32003
Contact Research: 904-680-0871